Associate Professor - CSO
Uppsala University - Phenaros Pharmaceuticals, Sweden
Jordi Carreras-Puigvert is Associate Professor in preclinical drug discovery, and co-leads the Pharmaceutical Bioinformatics group (https://pharmb.io/) at Uppsala University, Sweden. He holds a PhD in Life Science from the university of Leiden, the Netherlands, and prior to moving to Uppsala University, he was co-leading the Cancer Therapy group, focused on phenotypic drug discovery, at Karolinska Institutet in Stockholm. Jordi Carreras-Puigvert is also Chief Scientific Officer at Phenaros Pharmaceuticals (https://www.phenaros.com/), an AI-first drug discovery startup. The pharmb.io research group is pioneering the use of Cell Painting-based morphological profiling for prediction of mechanism of action, as well as academic drug discovery. As CSO of Phenaros, Carreras-Puigvert focuses on the exploitation of the company’s drug discovery platform leveraging phenomics, AI and automation.